TY  - JOUR
AU  - Zhang, Gui-Jun
AU  - Ma, Xiu-Jian
AU  - Zhang, Ya-Ping
AU  - Hao, Li-Fang
AU  - Wang, Liang
AU  - Zhang, Jun-Ting
AU  - Wu, Zhen
AU  - Li, Da
TI  - Surgical management and outcome of primary intracranial Rosai-Dorfman disease: a single-institute experience and pooled analysis of individual patient data.
JO  - Neurosurgical review
VL  - 46
IS  - 1
SN  - 0344-5607
CY  - New York
PB  - Springer
M1  - DKFZ-2023-00612
SP  - 76
PY  - 2023
N1  - DKFZ-ZMBH Alliance
AB  - Primary intracranial Rosai-Dorfman disease (PIRDD) is considered a nonmalignant nonneoplastic entity, and the outcome is unclear due to its rarity. The study aimed to elaborate the clinic-radiological features, treatment strategies, and progression-free survival (PFS) in patients with PIRDD. Patients with pathologically confirmed PIRDD in our institute were reviewed. Literature of PIRDD, updated until December 2019, was systematically searched in 7 databases (Embase, PubMed, Cochrane database, Web of Science, Wanfang Data Knowledge Service Platform, the VIP Chinese Science and Technology Periodical Database (VIP), and the China National Knowledge Infrastructure (CNKI)). These prior publication data were processed and used according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Clinical-radiological characteristics and adverse factors for PFS were evaluated in the pooled cohort. The pooled cohort of 124 cases (81 male and 43 female), with a mean age of 39.7 years, included 11 cases from our cohort and 113 cases from 80 prior studies. Twenty-nine patients (23.4
KW  - Primary intracranial Rosai-Dorfman disease (Other)
KW  - Radiotherapy (Other)
KW  - Steroid therapy (Other)
KW  - Surgical resection (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36967440
DO  - DOI:10.1007/s10143-023-01983-9
UR  - https://inrepo02.dkfz.de/record/274467
ER  -